Skip to main content

Table 4 Survival outcomes of patients with premalignant lesions and cholangiocarcinoma

From: Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area

Diagnosis Patients with Premalignant lesions Cholangiocarcinoma patients
Resectable Unresectable
  1-year 2-year 1-year 2-year 1-year 2-year
OS 100 % 100 % 75 % 44.4 % 33.3 % 0 %
DFS/PFS 100 % 100 % 100 % 77.8 % 66.7 % 25 %
  1. Abbreviations: OS overall survival, PFS progression free survival, DFS disease free survival